A designed antimicrobial peptide with potential ability against methicillin resistant Staphylococcus aureus

Bingqian Yuan(Tianjin University), Zilei Duan(Kunming Institute of Zoology), Zhuocen Cha(Kunming Medical University), Jingting Yan(Yunnan Province Science and Technology Department), Qiyi He(Chongqing Normal University), Aili Wang(Jiangsu University), Xiaodong Yu(Chongqing Normal University), Min Yang(Chinese Academy of Sciences), Xiaoyu Lu(Tianjin University), Yan Yang(Yunnan Province Science and Technology Department), Lei Xu(Yunnan Province Science and Technology Department), Yaqun Fang(Kunming Institute of Zoology), Ren Lai(Kunming Institute of Zoology)
Frontiers in Microbiology
October 10, 2022
10.3389/fmicb.2022.1029366
Cited by 9

Related Papers

SARS-CoV-2 M <sup>pro</sup> inhibitors with antiviral activity in a transgenic mouse model
|Science|2021|449
The antimicrobial peptide ZY4 combats multidrug-resistant <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii</i> infection
|Proceedings of the National Academy of Sciences|2019|288
Odorranalectin-conjugated nanoparticles: Preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration
|Journal of Controlled Release|2011|242
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target
|Cell Research|2021|198
Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models
|Cell Research|2020|120